Martin Shkreli (AP Photo/Susan Walsh, File)
‘Pharma Bro’ Martin Shkreli's companies file for bankruptcy
The company founded by Martin Shkreli, the “Pharma Bro” known for hiking the price of an old drug by 4,000%, has filed for Chapter 11 bankruptcy in Delaware.
Vyera Pharmaceuticals, which is the rebranded version of Shkreli’s Turing Pharmaceuticals, its parent company Phoenixus AG and four other companies filed for Chapter 11 protection on Wednesday, according to documents from the US Bankruptcy Court for the District of Delaware. The case filing for Vyera states that the pharma plans to have a sale or liquidation of the “liquidating debtors” and for Phoenixus to be preserved.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters